FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029141105> ?p ?o ?g. }

• W2029141105 endingPage "4" @default.
• W2029141105 startingPage "1" @default.
• W2029141105 abstract "Indispensable for shortening treatment of drug-susceptible tuberculosis (TB), pyrazinamide (PZA, Z) is also essential in the treatment of multidrug-resistant (MDR)-TB. While resistance to PZA in MDR-TB is associated with poor treatment outcome, bacillary susceptibility to PZA along with the use of fluoroquinolone (FQ) and second-line injectable drugs (SLIDs) may predict improved treatment success in MDR-TB. Despite a high prevalence of PZA resistance among MDR-TB patients (10%-85%), PZA susceptibility testing is seldom performed because of technical challenges. To improve treatment of MDR-TB, we propose to: (i) classify MDR-TB into PZA-susceptible MDR-TB (Z(S)-MDR-TB) and PZA-resistant MDR-TB (Z(R)-MDR-TB); (ii) use molecular tests such as DNA sequencing (pncA, gyrA, rrs, etc.) to rapidly identify Z(S)-MDR-TB versus Z(R)-MDR-TB and susceptibility profile for FQ and SLID; (iii) refrain from using PZA in Z(R)-MDR-TB; and (iv) explore the feasibility of shortening the treatment duration of Z(S)-MDR-TB with a regimen comprising PZA plus at least two bactericidal agents especially new agents like TMC207 or PA-824 or delamanid which the bacilli are susceptible to, with one or two other agents. These measures may potentially shorten therapy, save costs, and reduce side effects of MDR-TB treatment." @default.
• W2029141105 created "2016-06-24" @default.
• W2029141105 creator A5001255521 @default.
• W2029141105 creator A5042973046 @default.
• W2029141105 creator A5052262194 @default.
• W2029141105 creator A5057332945 @default.
• W2029141105 creator A5071106707 @default.
• W2029141105 creator A5072012689 @default.
• W2029141105 creator A5090415157 @default.
• W2029141105 creator A5091510502 @default.
• W2029141105 creator A5091735303 @default.
• W2029141105 date "2012-07-01" @default.
• W2029141105 modified "2023-10-15" @default.
• W2029141105 title "‘Z^S-MDR-TB’ versus ‘Z^R-MDR-TB’: improving treatment of MDR-TB by identifying pyrazinamide susceptibility" @default.
• W2029141105 cites W108806092 @default.
• W2029141105 cites W128341503 @default.
• W2029141105 cites W1538374398 @default.
• W2029141105 cites W1805880101 @default.
• W2029141105 cites W1923394711 @default.
• W2029141105 cites W1972783452 @default.
• W2029141105 cites W1975610050 @default.
• W2029141105 cites W1986629453 @default.
• W2029141105 cites W1987133508 @default.
• W2029141105 cites W1991974760 @default.
• W2029141105 cites W1995309322 @default.
• W2029141105 cites W1996794817 @default.
• W2029141105 cites W1998828531 @default.
• W2029141105 cites W2004753123 @default.
• W2029141105 cites W2007356014 @default.
• W2029141105 cites W2047701762 @default.
• W2029141105 cites W2065130119 @default.
• W2029141105 cites W2072909861 @default.
• W2029141105 cites W2077892389 @default.
• W2029141105 cites W2080241120 @default.
• W2029141105 cites W2089154924 @default.
• W2029141105 cites W2093397591 @default.
• W2029141105 cites W2098335911 @default.
• W2029141105 cites W2098793988 @default.
• W2029141105 cites W2099109129 @default.
• W2029141105 cites W2102321517 @default.
• W2029141105 cites W2112139993 @default.
• W2029141105 cites W2119960901 @default.
• W2029141105 cites W2120833699 @default.
• W2029141105 cites W2121886790 @default.
• W2029141105 cites W2124127309 @default.
• W2029141105 cites W2129047823 @default.
• W2029141105 cites W2129716166 @default.
• W2029141105 cites W2132102995 @default.
• W2029141105 cites W2133783230 @default.
• W2029141105 cites W2134476763 @default.
• W2029141105 cites W2139562897 @default.
• W2029141105 cites W2145983374 @default.
• W2029141105 cites W2146817473 @default.
• W2029141105 cites W2150867622 @default.
• W2029141105 cites W2152352130 @default.
• W2029141105 cites W2154718868 @default.
• W2029141105 cites W2154740388 @default.
• W2029141105 cites W2156272262 @default.
• W2029141105 cites W2158579718 @default.
• W2029141105 cites W2158658436 @default.
• W2029141105 cites W2159842507 @default.
• W2029141105 cites W2166758514 @default.
• W2029141105 cites W2167629505 @default.
• W2029141105 cites W2172307391 @default.
• W2029141105 cites W2406106160 @default.
• W2029141105 cites W2416847361 @default.
• W2029141105 cites W36895966 @default.
• W2029141105 cites W4229917921 @default.
• W2029141105 cites W4297957182 @default.
• W2029141105 cites W69001215 @default.
• W2029141105 doi "https://doi.org/10.1038/emi.2012.18" @default.
• W2029141105 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3630910" @default.
• W2029141105 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26038418" @default.
• W2029141105 hasPublicationYear "2012" @default.
• W2029141105 type Work @default.
• W2029141105 sameAs 2029141105 @default.
• W2029141105 citedByCount "38" @default.
• W2029141105 countsByYear W20291411052012 @default.
• W2029141105 countsByYear W20291411052013 @default.
• W2029141105 countsByYear W20291411052014 @default.
• W2029141105 countsByYear W20291411052015 @default.
• W2029141105 countsByYear W20291411052016 @default.
• W2029141105 countsByYear W20291411052017 @default.
• W2029141105 countsByYear W20291411052018 @default.
• W2029141105 countsByYear W20291411052019 @default.
• W2029141105 countsByYear W20291411052020 @default.
• W2029141105 countsByYear W20291411052022 @default.
• W2029141105 countsByYear W20291411052023 @default.
• W2029141105 crossrefType "journal-article" @default.
• W2029141105 hasAuthorship W2029141105A5001255521 @default.
• W2029141105 hasAuthorship W2029141105A5042973046 @default.
• W2029141105 hasAuthorship W2029141105A5052262194 @default.
• W2029141105 hasAuthorship W2029141105A5057332945 @default.
• W2029141105 hasAuthorship W2029141105A5071106707 @default.
• W2029141105 hasAuthorship W2029141105A5072012689 @default.
• W2029141105 hasAuthorship W2029141105A5090415157 @default.
• W2029141105 hasAuthorship W2029141105A5091510502 @default.
• W2029141105 hasAuthorship W2029141105A5091735303 @default.

• next